Value of cytokeratin 5/6 immunostaining using D5/16 B4 antibody in the spectrum of proliferative intraepithelial lesions of the breast. A comparative study with 34βE12 antibody

Virchows Archiv

Volumn 442, Issue 6, 2003, Pages 548-554

  Lacroix Triki, Magali ^a   Mery, Eliane ^a   Voigt, Jean Jacques ^a   Istier, Luc ^a   Rochaix, Philippe ^a  

^a INSTITUT CLAUDIUS REGAUD   (France)

Author keywords

Atypical hyperplasia; Breast; Cytokeratin 5 6; Ductal and lobular carcinoma in situ; Hyperplasia

Indexed keywords

CYTOKERATIN;

ARTICLE; BREAST DUCT; BREAST EPITHELIUM; BREAST HYPERPLASIA; BREAST LESION; CANCER CELL; CELL LABELING; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; PRIORITY JOURNAL;

EID: 0038008282     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-003-0808-0     Document Type: Article

References (28)

1. Bodian CA, Perzin KH, Lattes R, Hoffman P, Abernathy TG (1993) Prognostic significance of benign proliferative breast disease. Cancer 71:3896-3907
2. Boecker W, Bier B, Freytag G, Brommelkamp B, Jarasch ED, Edel G, Dockhom-Dworniczak B, Schmid KW (1992) An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV, and laminin. Part I: normal breast and benign proliferative lesions. Virchows Arch 421:315-322
3. Boecker W, Bier B, Freytag G, Brommelkamp B, Jarasch ED, Edel G, Dockhorn-Dworniczak B, Schmid KW (1992) An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV, and laminin. Part II: epitheliosis and ductal carcinoma in situ. Virchows Arch 421:323-330
4. Boecker W, Buerger H, Schmitz K, Ellis IA, Van Diest PJ, Sinn HP, Geradts J, Diallo R, Poremba C, Herbst H (2001) Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns. J Pathol 195:415-421
5. Bratthauer GL, Moinfar F, Stamatakos MD, Mezzetti TP, Shekitka KM, Man YG, Tavassoli FA (2002) Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. Hum Pathol 33:620-627
6. Dairkee SH, Mayall BH, Smith HS, Hackett AJ (1987) Monoclonal marker that predicts early recurrence of breast cancer. Lancet 1:514
7. Dairkee SH, Puett L, Hackett AJ (1988) Expression of basal and luminal epithelium-specific keratins in normal, benign, and malignant breast tissue. J Natl Cancer Inst 80:691-695
8. Dupont WD, Pad FF, Hartmann WH, Brinton LA, Winfield AC, Worrel JA, Schuyler PA, Plummer BS (1993) Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71:1258-1265
9. Guelstein VI, Tchypysheva TA, Ermilova VD, Litvinova LV, Troyanovski SM, Bannikov GA (1988) Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human mammary gland, benign tumors, dysplasias and breast cancer. Int J Cancer 42:147-153
10. Heatley M, Maxwell P, Whiteside C, Toner P (1995) Cytokeratin intermediate filament expression in benign and malignant breast disease. J Clin Pathol 48:26-32
11. Jarasch ED, Nagle RB, Kaufmann M, Maurer C, Böcker WJ (1988) Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins. Hum Pathol 19:276-289
12. Malzahn K, Mitze M, Thoenes M, Moll R (1998) Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breasts carcinomas. Virchows Arch 433:119-129
13. Moinfar F, Man YG, Lininger RA, Bodian C, Tavassoli FA (1999) Use of keratin 34βE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type benign and malignant intraductal proliferations. Am J Surg Pathol 23:1048-1058
14. Otterbach F, Bànkfalvi A, Bergner S, Decker T, Krech R, Boecker W (2000) Cytokeratin 5/6-immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathology 37:232-240
15. Raju U, Crissman JD, Zarbo RJ, Gottlieb C (1990) Epitheliosis of the breast: an immunohistochemical characterization and comparison to malignant intraductal proliferations of the breast. Am J Surg Pathol 14:939-947
16. Santini D, Cecarelli C, Taffurelli M, Piled S, Marrano D (1996) Differentiation pathways in primary invasive breast carcinoma as suggested by intermediate filament and biopathological marker expression. J Pathol 179:386-391
17. Schnitt SJ, Connoly JL, Tavassoli FA, Fechner RE, Kempson RL, Gelman R, Page DL (1992) Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol 16:1133-1143
18. Schwartz GF, Solin LJ, Olivotto IA, Emster VL, Pressman PI, and the consensus conference committee (2000) The consensus conference on the treatment of in situ ductal carcinoma of the breast, 22-25 April 1999. Hum Pathol 31:131-138
19. Shi SR, Key ME, Kalra KL (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissues sections. J Histochem Cytochem 39:741-748
20. Shoker BS, Sloane JP (1999) DCIS grading schemes and clinical implications. Histopathology 35:393-400
21. Silverstein MJ, Poller DN, Waisman JR (1995) Prognostic classification of breast ductal carcinoma in situ. Lancet 345:1154-1157
22. Sloane JP, Ormerod MG (1981) Distribution of epithelial membrane antigen in normal and neoplastic tissues and its value in diagnostic tumor pathology. Cancer 47:1786-1795
23. Soini Y, Miettinen M (1992) Immunohistochemical evaluation of the cytoarchitecture of benign and malignant breast lesions. APMIS 100:901-907
24. Tavassoli FA (1999) Pathology of the breast. Appleton and Lange, Stanford, Connecticut
25. Tavassoli FA, Man Y (1995) Morphofunctional features of intraductal hyperplasia, atypical intraductal hyperplasia and various grades of intraductal carcinoma. Breast J 1:155-162
26. Tavassoli FA, Norris HJ (1990) A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 65:518-529
27. Viacava P, Naccarato AG, Bevilacqua G (1999) Different proliferative patterns characterize different preinvasive breast lesions. J Patrol 188:245-251
28. Wetzels RHW, Kuijpers HJH, Lane EB, Leigh IM, Troyanovsky SM, Holland R, van Haelst UJGM, Ramaekers FCS (1991) Basal cell-specific and hyperproliferation-related keratins in human breast cancer. Am J Pathol 138:751-763